Kymos Group is a GMP/GLP-certified analytical services firm spanning bioanalysis, CMC, and batch-release testing for small molecules, biologics, and advanced therapies. The tech stack reveals a hybrid operation: lab-heavy (LC-MS/MS, HPLC, qPCR, LabWare LIMS) layered on ERP and CRM infrastructure (SAP, NetSuite, Salesforce), with Python and SQL anchoring data workflows. Active hiring across research and quality teams aligns with the core workload — method development, stability studies, and quality-system strengthening — while LIMS productivity optimization sits high on the challenge list, suggesting the lab-information ecosystem is a bottleneck.
Kymos Group operates three laboratory facilities across Spain, Italy, and Germany, delivering analytical and quality-control services to biotech, pharma, generics, veterinary, cosmetics, and nutraceutical customers. The service portfolio spans bioequivalence studies, preclinical and clinical bioanalysis (LC-MS/MS, immunoassay, cell-based), CMC support (analytical method development, stability, batch release), and specialized testing (immunogenicity, photostability, in vitro absorption). The company has undergone EMA and FDA inspection; it holds GMP and GLP certifications. With 201–500 employees and a research-and-quality-dominant hiring mix, Kymos operates as a service-delivery organization anchored in lab execution and regulatory compliance.
Lab instruments: LC-MS/MS, HPLC, UHPLC, qPCR. LIMS: LabWare. ERP/CRM: SAP, NetSuite, Salesforce. Analysis tools: GraphPad Prism, Phoenix WinNonlin. Data/scripting: Python, SQL, JavaScript.
Bioanalysis (bioequivalence, preclinical/clinical sample testing, immunoassay, immunogenicity); CMC (method development, validation, stability, batch release); and specialized testing (microbiology, photostability, in vitro absorption).
Other companies in the same industry, closest in size